Patient eligibility
- Not satisfied with results of antidepressants
- Responded to medication but not in remission
- Struggling with medication side effects
- Has failed 2 or more medication trials
- Prefers to avoid antidepressants or augmentors
For referring providers
Collaborative care starts here
Not sure if your patient is eligible for TMS or Spravato? Let us handle the evaluation. We assess eligibility, build a personalized plan, and keep you informed throughout treatment.
Use these checklists as a starting point. We still evaluate each patient individually and confirm coverage before treatment begins.
We assess your patient for TMS or Spravato, create a personalized treatment plan, and keep you updated every step of the way.
Three simple steps from your referral to coordinated care.
Share the patient’s name, DOB, insurance, diagnosis, and medication history. Fax (240) 599-1002 or call (240) 599-1001.
Our team evaluates fit for TMS, Spravato, or IM ketamine, verifies benefits, and handles prior authorization when needed.
We create a personalized plan and keep you updated on evaluation findings, treatment start, and progress.
Advanced options for adults with treatment-resistant depression and related conditions across Maryland.
Call or fax during business hours. Our coordinators verify insurance, assess eligibility, and schedule the evaluation at Rockville or Frederick.
No. Patients can book directly. Referring providers are welcome to send clinical information so we can coordinate care and keep you informed.
We commonly receive referrals for Deep TMS, Spravato (esketamine), IM ketamine, psychiatric evaluation, and medication management for treatment-resistant depression and related conditions.
Patient demographics, diagnosis, current medications, prior antidepressant trials (names, doses, duration, response), relevant labs or notes, and insurance details help us move quickly on eligibility and prior auth.
Yes. With appropriate consent, we keep referring providers informed about eligibility, the treatment plan, and clinical progress for TMS or Spravato pathways.
Yes. We accept major commercial plans, Medicare, and Maryland Medicaid. We verify benefits before treatment begins.